MiRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2018 Feb 3

PMID 29392135

Citations 16

Authors

LongJiao Ran

Jian Liang

Xin Deng

Jinyu Wu

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma (RCC) is the most common type of urinary malignancy. Clear cell renal cell carcinoma (ccRCC) is the predominant RCC subtype, accounting for 70-80% of RCC. In recent years, miRNAs have been found to be closely associated with the outcome of the patients with ccRCC. In this review, we summarize recent advances in research exploring the role of miRNAs in predicting prognosis in patients with ccRCC.

Citing Articles

Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis.

Wang Y, Zhang Y, Su X, Qiu Q, Yuan Y, Weng C Int J Biol Sci. 2022; 18(4):1491-1507.

PMID: 35280687 PMC: 8898370. DOI: 10.7150/ijbs.69351.

miR-25-3p protects renal tubular epithelial cells from apoptosis induced by renal IRI by targeting DKK3.

Zhang Y, Zuo X Open Life Sci. 2022; 16(1):1393-1404.

PMID: 35174294 PMC: 8812715. DOI: 10.1515/biol-2021-0127.

Down regulation of miR-30a-5p and miR-182-5p in gastric cancer: Clinical impact and survival analysis.

Soliman S, Elabd N, El-Kousy S, Awad M Biochem Biophys Rep. 2021; 27:101079.

PMID: 34355069 PMC: 8321916. DOI: 10.1016/j.bbrep.2021.101079.

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.

Kinget L, Roussel E, Verbiest A, Albersen M, Rodriguez-Antona C, Grana-Castro O Cancers (Basel). 2021; 13(12).

PMID: 34205829 PMC: 8235409. DOI: 10.3390/cancers13123099.

Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).

Wang W, Gan Z, Liu Q, Yan S, Mulati R, Wang Y Bioengineered. 2021; 12(1):2957-2969.

PMID: 34180759 PMC: 8806489. DOI: 10.1080/21655979.2021.1943112.

References

Huang Q, Ma X, Zhang X, Liu S, Ai Q, Shi T . Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4. PLoS One. 2013; 8(6):e67294. PMC: 3694928. DOI: 10.1371/journal.pone.0067294. View

Teng J, Gao Y, Chen M, Wang K, Cui X, Liu Y . Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma. Chin Med J (Engl). 2014; 127(9):1640-4. View

Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X . miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Clin Cancer Res. 2014; 20(10):2617-30. DOI: 10.1158/1078-0432.CCR-13-3224. View

Chen X, Ruan A, Wang X, Han W, Wang R, Lou N . miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. J Cancer Res Clin Oncol. 2014; 140(8):1295-304. DOI: 10.1007/s00432-014-1690-7. View

Vergho D, Kneitz S, Kalogirou C, Burger M, Krebs M, Rosenwald A . Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava. PLoS One. 2014; 9(10):e109877. PMC: 4184907. DOI: 10.1371/journal.pone.0109877. View

Fan W, Huang J, Xiao H, Liang Z . MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN. Mol Med Rep. 2016; 13(6):4800-6. DOI: 10.3892/mmr.2016.5101. View

Zhao X, Zhao Z, Xu W, Hou J, Du X . Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Int J Clin Exp Pathol. 2015; 8(1):758-64. PMC: 4348935. View

Zhao J, Lei T, Xu C, Li H, Ma W, Yang Y . MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun. 2013; 438(2):439-44. DOI: 10.1016/j.bbrc.2013.07.095. View

Li H, Zhao J, Zhang J, Huang Q, Huang J, Chi L . MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration. Neoplasma. 2013; 60(5):511-5. DOI: 10.4149/neo_2013_066. View

10.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A . MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases. Ann Surg Oncol. 2013; 21(3):1046-54. DOI: 10.1245/s10434-013-3361-3. View

11.

Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng Q . LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer. PLoS One. 2014; 9(6):e100557. PMC: 4067378. DOI: 10.1371/journal.pone.0100557. View

12.

Li W, Liu M, Feng Y, Xu Y, Huang Y, Che J . Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer. 2014; 111(6):1188-200. PMC: 4453839. DOI: 10.1038/bjc.2014.382. View

13.

Samaan S, Khella H, Girgis A, Scorilas A, Lianidou E, Gabril M . miR-210 is a prognostic marker in clear cell renal cell carcinoma. J Mol Diagn. 2015; 17(2):136-44. DOI: 10.1016/j.jmoldx.2014.10.005. View

14.

Lou N, Ruan A, Qiu B, Bao L, Xu Y, Zhao Y . miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Urol Oncol. 2016; 35(1):36.e7-36.e14. DOI: 10.1016/j.urolonc.2016.07.012. View

15.

Ge Y, Wu R, Xin H, Zhu M, Lu T, Liu H . A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol. 2015; 141(7):1291-9. DOI: 10.1007/s00432-015-1927-0. View

16.

Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J . miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2. Diagn Pathol. 2015; 10:24. PMC: 4419389. DOI: 10.1186/s13000-015-0255-7. View

17.

Gebauer K, Peters I, Dubrowinskaja N, Hennenlotter J, Abbas M, Scherer R . Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma. Br J Cancer. 2013; 108(1):131-8. PMC: 3553529. DOI: 10.1038/bjc.2012.537. View

18.

Yang F, Zhang H, Zhang H, Chen S, Yan Y, Zheng J . MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1. PLoS One. 2015; 10(3):e0120258. PMC: 4368579. DOI: 10.1371/journal.pone.0120258. View

19.

Xiao H, Xiao W, Cao J, Li H, Guan W, Guo X . miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma. Cancer Lett. 2016; 374(1):107-116. DOI: 10.1016/j.canlet.2016.01.032. View

20.

Nofech-Mozes R, Khella H, Scorilas A, Youssef L, Krylov S, Lianidou E . MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Med. 2016; 5(4):656-64. PMC: 4831284. DOI: 10.1002/cam4.631. View